Grau R G, Kassan S S, Franks J J, Kaplan H, Walker S H, Tan E M
Ann Rheum Dis. 1984 Oct;43(5):721-4. doi: 10.1136/ard.43.5.721.
Postulating an increased production of fibrin(ogen)olytic degradation products (FDP) and an abnormality of fibrinogen metabolism in polymyalgia rheumatica (PMR) and temporal arteritis (TA), we studied 16 PMR/TA patients and 10 control subjects using a sensitive radioimmunoassay for a specific type of FDP, namely, fibrin(ogen)-related D-antigen. Median serum D-antigen levels were increased five-fold in those 11 PMR/TA patients who were untreated compared with control subjects. In the five PMR/TA patients who were treated with prednisone the median D-antigen levels were not significantly different from those of the healthy controls. D-antigen concentration correlated significantly (r = 0.83) with ESR in the seven untreated PMR patients. In PMR patients prednisone therapy was followed by a reduction of serum D-antigen levels.
鉴于风湿性多肌痛(PMR)和颞动脉炎(TA)中纤维蛋白(原)溶解降解产物(FDP)生成增加以及纤维蛋白原代谢异常的假设,我们使用一种针对特定类型FDP(即纤维蛋白(原)相关D抗原)的灵敏放射免疫分析法,对16例PMR/TA患者和10名对照受试者进行了研究。与对照受试者相比,11例未接受治疗的PMR/TA患者的血清D抗原水平中位数升高了五倍。在接受泼尼松治疗的5例PMR/TA患者中,D抗原水平中位数与健康对照者无显著差异。在7例未接受治疗的PMR患者中,D抗原浓度与红细胞沉降率(ESR)显著相关(r = 0.83)。在PMR患者中,泼尼松治疗后血清D抗原水平降低。